Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Harvard Bioscience Inc (HBIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harvey Partners Jeffrey Moskowitz | 2,141,099 | $950,220 | -3% | 0.09% |
| 2. | Meros Investment Management Timothy Chatard | 919,945 | $408,288 | +16% | 0.19% |
| 3. | Renaissance Technologies Jim Simons | 791,978 | $351,480 | -11% | 0% |
| 4. | Millennium Management Israel Englander | 639,867 | $283,973 | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 138,700 | $61,028 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.91 | 10,000 | $29,100.00 | 3,111,091 | 2024-06-13 | Filing | |
| $3.07 | 20,000 | $61,400.00 | 3,101,091 | 2024-06-06 | Filing | |
| $4.38 | 25,000 | $109,500.00 | 2,862,679 | 2023-08-17 | Filing | |
| $2.62 | 16,192 | $42,423.04 | 202,485 | 2023-03-15 | Filing | |
| $2.67 | 13,808 | $36,867.36 | 186,293 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.02 | 48,175 | $386,363.50 | 2,091,725 | 2021-08-23 | Filing | |
| $7.14 | 24,312 | $173,587.68 | 2,279,778 | 2021-05-21 | Filing | |
| $7.03 | 14,876 | $104,578.28 | 2,279,778 | 2021-05-20 | Filing | |
| $7.17 | 39,188 | $280,977.96 | 2,279,778 | 2021-05-19 | Filing | |
| $7.41 | 39,188 | $290,383.08 | 2,279,788 | 2021-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,508,703 | $1,557,162 | 2.05% | |
| 2. | 1,853,891 | $823,127 | 0% | |
| 3. | 1,501,508 | $666,369 | 0.03% | |
| 4. | 1,126,250 | $499,888 | 0% | |
| 5. | 1,114,575 | $494,648 | 0% |
News See All
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript
Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Harvard Bioscience, Inc. Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to Harvard Bioscience's Second Quarter 2023 Earnings Call.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Harvard Bioscience First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
Billionaire Hedge Funds
